Core Scientific, Inc. Form 8-K Summary
Business context and reporting period
Core Scientific, Inc. filed a Form 8-K reporting actions approved by its Audit Committee on October 24, 2022. The filing was signed and submitted on October 28, 2022. The company’s common stock and warrants trade on Nasdaq under CORZ and CORZW, respectively.
Auditor change
- The Audit Committee approved the engagement of Marcum LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2022, subject to completion of Marcum’s client acceptance procedures.
- Ernst & Young LLP was approved for dismissal effective upon filing of the company’s Form 10-Q for the quarter ended September 30, 2022.
- EY’s prior reports on Legacy Core’s 2020 and 2021 financial statements contained no adverse opinion, disclaimer of opinion, or qualification relating to uncertainty, audit scope, or accounting principles.
Financial metrics and liquidity
This filing does not provide revenue, profit, cash flow, margin, debt, liquidity, or other operating performance figures.
Material changes, controls, and risks
The filing states that there were no disagreements with EY regarding accounting principles or practices, financial statement disclosures, or audit scope and procedures. It also reports no reportable events other than material weaknesses in internal control over financial reporting identified during audits and interim reviews.
- Insufficient technical accounting expertise, supervision, and processes for applying the relevant accounting framework, particularly in new or non-routine areas.
- Inadequate communication and recordkeeping, particularly relating to equity transactions.
- Control design deficiencies affecting segregation of duties for manual journal entries.
- Control design deficiencies affecting segregation of duties for digital asset wallets.
The company requested that EY provide a letter to the SEC stating whether it agrees with the company’s disclosures. The filing identifies EY’s October 28, 2022 letter as Exhibit 16.1.
Guidance, outlook, and unusual items
The filing contains no financial guidance, operating outlook, management forecast, contingency disclosure, or other unusual item beyond the auditor transition and reported internal-control material weaknesses.
Key facts investors should verify
- Whether Marcum completed its client acceptance procedures and formally assumed the 2022 audit engagement.
- The effective date of EY’s dismissal and the filing of the September 30, 2022 Form 10-Q.
- The contents of EY’s Exhibit 16.1 letter and whether EY agreed with the company’s statements.
- Remediation progress for the four reported internal-control material weaknesses.
- Any subsequent financial, liquidity, or going-concern disclosures in the September 30, 2022 Form 10-Q or later filings.